Health Equity

  • Dr. Monica Soni Selected to Participate in the Carol Emmott Fellowship

    Dr. Monica Soni Selected to Participate in the Carol Emmott Fellowship

    Our associate chief medical officer is among the few women leaders in healthcare chosen for this prestigious experience.

    Read External Article
  • When Equality and Health Equity Diverge

    When Equality and Health Equity Diverge

    Treating patients the same isn't always the path to improved outcomes, writes our associate chief medical officer.

    Read Article
  • ×

    First Name
    Last Name
    Company Name
    Thank you!
    Error - something went wrong!
  • Leading Causes: Interrogating the “Why” Behind Health Inequity in Cancer Care

    Leading Causes: Interrogating the “Why” Behind Health Inequity in Cancer Care

    How do social determinants of health impact outcomes in cancer care? New Century Health Associate CMO Dr. Monica Soni and Radiation Oncologist Dr. Onyinye Balogun discuss.

    Watch Video
  • The Pandemic's Disproportionate Impact on Health Care Disparities and Cancer

    The Pandemic's Disproportionate Impact on Health Care Disparities and Cancer

    Our associate chief medical officer shares her insights with the American Journal of Managed Care's podcast.

    Listen to Podcast
  • Developing a playbook to tackle health inequities in cancer care

    Developing a playbook to tackle health inequities in cancer care

    New Century Health Associate Chief Medical Officer Monica Soni explores health inequities in cancer cares and shares strategies for how to address them.

    Watch Video
  • New Century Health Reports Year of Record Growth and Clinical Innovation in 2020

    New Century Health Reports Year of Record Growth and Clinical Innovation in 2020

    New Century Health announced that 2020 was the largest membership growth year in the 19-year history of the company.

    Read Article
  • Can Clinical Pathways Help Combat Health Care Disparities?

    Can Clinical Pathways Help Combat Health Care Disparities?

    A new research effort aims to gauge whether certain groups of patients receive high-value therapies at lower rates than others.

    Read Article
  • loading
    Loading More...